Abstract
These findings suggest aspirin and meloxicam modulate breast cancer cells survival by interfering both cell cycle independent (mitochondrial Bcl-2) and cycle-dependent (survivin) apoptotic pathways. The COX inhibitors efficiently prevented the cdc2-survivin complex activation by reducing the phosphorylation of cdc2 and c-raf. They modulate the anti-apoptotic effect of bFGF independent of COX II activities. The anti-survivin properties of aspirin and meloxicam in our in vitro model may explain the chemoprevention role of COX inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Irish Journal of Medical Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
